Literature DB >> 16807801

Myoepithelial cells in the control of mammary development and tumorigenesis: data from genetically modified mice.

Marisa M Faraldo1, Jérôme Teulière, Marie-Ange Deugnier, Ilaria Taddei-De La Hosseraye, Jean Paul Thiery, Marina A Glukhova.   

Abstract

Until recently, myoepithelial cells-the second major cell population in the mammary epithelium-were not considered to play an important role in the morphogenetic events during gland development. Mouse mutants with changes in the gene expression pattern characteristic of the basal myoepithelial cell layer have been generated and used to show that these cells influence the proliferation, survival and differentiation of luminal cells, modulate stromal-epithelial interactions and actively participate in mammary morphogenesis. Various cellular and molecular mechanisms may underlie the observed phenotypes. These include an unbalanced expression of matrix degrading metalloproteinases (MMPs) and their inhibitors, leading to changes in the composition and organization of the (extracellular matrix) ECM, the production of soluble growth factors affecting stromal and epithelial cell growth and differentiation and direct signaling through cell-cell contacts between the myoepithelial and luminal cell layers.

Entities:  

Mesh:

Year:  2005        PMID: 16807801     DOI: 10.1007/s10911-005-9582-8

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.698


  58 in total

1.  Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice.

Authors:  C H Liu; S H Chang; K Narko; O C Trifan; M T Wu; E Smith; C Haudenschild; T F Lane; T Hla
Journal:  J Biol Chem       Date:  2001-03-07       Impact factor: 5.157

2.  p63 is a p53 homologue required for limb and epidermal morphogenesis.

Authors:  A A Mills; B Zheng; X J Wang; H Vogel; D R Roop; A Bradley
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

Review 3.  Stem cells and breast cancer: A field in transit.

Authors:  Matthew Smalley; Alan Ashworth
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

4.  The myoepithelial defense: a host defense against cancer.

Authors:  M D Sternlicht; S H Barsky
Journal:  Med Hypotheses       Date:  1997-01       Impact factor: 1.538

5.  Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2.

Authors:  Karin Müller-Decker; Irina Berger; Karin Ackermann; Volker Ehemann; Svetlana Zoubova; Sebastian Aulmann; Walter Pyerin; Gerhard Fürstenberger
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

Review 6.  Cyclooxygenase-2: a potential target in breast cancer.

Authors:  Dingzhi Wang; Raymond N Dubois
Journal:  Semin Oncol       Date:  2004-02       Impact factor: 4.929

Review 7.  Cyclooxygenases in cancer: progress and perspective.

Authors:  Shan Zha; Vasan Yegnasubramanian; William G Nelson; William B Isaacs; Angelo M De Marzo
Journal:  Cancer Lett       Date:  2004-11-08       Impact factor: 8.679

8.  Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis.

Authors:  Karpagam Srinivasan; Phyllis Strickland; Ana Valdes; Grace C Shin; Lindsay Hinck
Journal:  Dev Cell       Date:  2003-03       Impact factor: 12.270

9.  Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium.

Authors:  N Barker; G Huls; V Korinek; H Clevers
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

10.  Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development.

Authors:  J J Wysolmerski; J F McCaughern-Carucci; A G Daifotis; A E Broadus; W M Philbrick
Journal:  Development       Date:  1995-11       Impact factor: 6.868

View more
  17 in total

1.  Altered differentiation and paracrine stimulation of mammary epithelial cell proliferation by conditionally activated Smoothened.

Authors:  Adriana P Visbal; Heather L LaMarca; Hugo Villanueva; Michael J Toneff; Yi Li; Jeffrey M Rosen; Michael T Lewis
Journal:  Dev Biol       Date:  2011-01-27       Impact factor: 3.582

2.  Myoepithelial Cells: Their Origin and Function in Lacrimal Gland Morphogenesis, Homeostasis, and Repair.

Authors:  Helen P Makarenkova; Darlene A Dartt
Journal:  Curr Mol Biol Rep       Date:  2015-07-10

3.  Biocompatible tissue scaffold compliance promotes salivary gland morphogenesis and differentiation.

Authors:  Sarah B Peters; Nyla Naim; Deirdre A Nelson; Aaron P Mosier; Nathaniel C Cady; Melinda Larsen
Journal:  Tissue Eng Part A       Date:  2014-02-27       Impact factor: 3.845

4.  Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts.

Authors:  Petra A B Klemmt; Vida Vafaizadeh; Bernd Groner
Journal:  Stem Cell Res Ther       Date:  2010-07-07       Impact factor: 6.832

Review 5.  Cellular foundations of mammary tubulogenesis.

Authors:  Robert J Huebner; Andrew J Ewald
Journal:  Semin Cell Dev Biol       Date:  2014-04-18       Impact factor: 7.727

6.  Progestin-regulated luminal cell and myoepithelial cell-specific responses in mammary organoid culture.

Authors:  Sandra Z Haslam; Alexis Drolet; Kyle Smith; May Tan; Mark Aupperlee
Journal:  Endocrinology       Date:  2008-01-24       Impact factor: 4.736

7.  Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes.

Authors:  Lisa M Arendt; Lindsay C Evans; Debra E Rugowski; Maria Jose Garcia-Barchino; Hallgeir Rui; Linda A Schuler
Journal:  J Endocrinol       Date:  2009-07-27       Impact factor: 4.286

8.  The MAPK(ERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium.

Authors:  Jimmie E Fata; Hidetoshi Mori; Andrew J Ewald; Hui Zhang; Evelyn Yao; Zena Werb; Mina J Bissell
Journal:  Dev Biol       Date:  2007-03-16       Impact factor: 3.582

9.  Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion.

Authors:  Sepi Mahooti; Kyle Porter; Mary L Alpaugh; Yin Ye; Yi Xiao; Susie Jones; Joseph D Tellez; Sanford H Barsky
Journal:  Oncotarget       Date:  2010-06

10.  Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation.

Authors:  Ahmed M Kotb; Andreas Hierholzer; Rolf Kemler
Journal:  Breast Cancer Res       Date:  2011-10-26       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.